Time-dependent modifications of splanchnic circulation in female pigs submitted to end-to-side portacaval anastomosis

Digestive Diseases and Sciences

Volumn 46, Issue 3, 2001, Pages 489-494

  Molino, G ^a   Avagnina, P ^a   Garrone, C ^a   Sansoe G ^a   Degerfeld, M M ^a   Peretti, P ^a   Tinivella, M ^a   Bianco, S ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Bioavailability; Portacaval anastomosis; Sorbitol clearance; Splanchnic circulation

Indexed keywords

SORBITOL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG CLEARANCE; DRUG ELIMINATION; END TO SIDE ANASTOMOSIS; FEMALE; FIRST PASS EFFECT; LIVER CLEARANCE; NONHUMAN; PATHOPHYSIOLOGY; PORTOCAVAL SHUNT; PRIORITY JOURNAL; SPLANCHNIC BLOOD FLOW; STEADY STATE; SUPERIOR MESENTERIC ARTERY; SWINE;

ANIMALS; BIOLOGICAL AVAILABILITY; FEMALE; PORTACAVAL SHUNT, SURGICAL; SORBITOL; SPLANCHNIC CIRCULATION; SWINE;

EID: 0035045682     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005678627599     Document Type: Article

References (19)

1. Enhanced bioavailability and decreased clearance of analgesics in patients with cirrhosis
2. Effect of portacaval shunt on the disposition of drugs with and without first-pass effect
3. Systemic availability of lidocaine in patients with liver disease
4. Propranolol disposition in chronic liver diseases: A physiological approach
5. Biological determinants of propranolol disposition in man
6. The influence of cirrhosis on steady-state blood concentrations of unbound propranolol after oral administration
7. Rifampicin and hepatic bile acid elimination
8. Altered drug metabolism and elevated serum bile acids in liver disease: A unified pharmacokinetic explanation
9. Noninvasive assessment of portalsystemic shunting: Evaluation of a method to investigate systemic availability of oral glyceryl trinitrate by digital plethysmography
10. Sorbitol clearance: A parameter reflecting liver plasma flow in the rat
11. Non-invasive evaluation of portalsystemic shunting in man by D-sorbitol bioavailability
12. Hepatic clearance of D-sorbitol. Noninvasive test for evaluating functional liver plasma flow
13. Steady-state extrarenal sorbitol clearance as a measure of hepatic plasma flow
14. Combined evaluation of total and functional liver plasma flows and intrahepatic shunting
15. Hydrogen breath test as a diagnostic method for sorbitol absorption in healthy adult
16. D-Sorbitol
17. Effects of percutaneous intrahepatic portosystemic shunt on splanchnic and systemic hemodynamics in patients with portal hypertension
18. Changes in liver perfusion caused by transjugular intrahepatic stent shunt
19. Adenosine as putative regulator of hepatic arterial flow (the buffer response)